InicioDía 2

Día 2

Thromboprophylaxis with antiplatelet agents in patients with mechanical aortic valves

Raúl García-Rinaldo2014-08-08MD, PhD, FACS Ponce School of Medicine, Ponce, PRMayaguez Medical Center, Mayaguez, PR

Hay Lugar Aun Para los Inhibidores GPIIbIIIa?

Pedro Ureña Velásquez2014-08-08FACC FSCAI FACCPDirector Medicina Cardiovascular Asociada     

Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Igor F. Palacios2014-08-08Director of Interventional CardiologyMassachusetts General HospitalProfessor of MedicineHarvard Medical School

Evaluation and Management of Asymptomatic Aortic Stenosis

Augusto Pichard2014-08-08Director Innovation and Structural Heart Disease,  Vice Chair, Medstar Heart Institute, Medstar Washington Hospital Center. Professor...

Below the Knee Interventions and Angiosome Concept

Luis A Guzman2014-08-08Director, Cardiovascular Cath LabUniversity of Florida-Jacksonville

LAA closure: Available Technology and Clinical Data

Gabriel Maluenda2014-08-08MD, FACCHospital San Borja Arriaran/Universidad de ChileClínica Alemana, Santiago, Chile

TAVI: Present and Future Perspective

Igor F. Palacios2014-08-08Director of Interventional CardiologyMassachusetts General HospitalProfessor of MedicineHarvard Medical School